Factors of loss to follow-up during tuberculosis treatment in a low-incidence region

被引:6
作者
Tetart, M. [1 ]
Meybeck, A. [1 ]
Assaf, A. [1 ]
Valette, M. [1 ]
Choisy, P. [1 ]
Blondiaux, N. [2 ]
Senneville, E. [1 ]
机构
[1] Ctr Hosp Dron, Serv Malad Infect, 135 Ave President Coty, F-59200 Tourcoing, France
[2] Ctr Hosp Dron, Lab Microbiol, F-59200 Tourcoing, France
来源
MEDECINE ET MALADIES INFECTIEUSES | 2020年 / 50卷 / 01期
关键词
Lost to follow-up; Compliance; Tuberculosis; Mycobacterium tuberculosis; MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; PATIENT ADHERENCE; NONADHERENCE; PREDICTORS; BARRIERS; OUTCOMES; DEFAULT; SUPPORT; EUROPE;
D O I
10.1016/j.medmal.2019.02.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective. - The proportion of successfully treated tuberculosis (TB) patients remains below the WHO target in France, because of a high proportion of loss to follow-up. We aimed to identify factors associated with loss to follow-up in northern France, a low-incidence area. Methods. - Between 1997 and 2017, all consecutive patients diagnosed with TB at the Tourcoing Hospital, except those infected with multidrug-resistant or extensively drug-resistant strains, were included in a retrospective cohort study. A logistic regression analysis was performed to determine factors associated with loss to follow-up. Results. - One hundred and ninety patients were included. Previous TB treatment was reported in 32 patients (17%), extrapulmonary TB in 107 (56%), and HIV infection in 44 (23%). The proportion of loss to follow-up was 15%. In multivariate analysis, the risk of loss to follow-up decreased in case of first TB treatment (OR 0.36; 95% CI: 0.14-0.92, P=0.03) and increased in non-HIV-infected patients (OR 7.67; 95% CI: 1.00-59.0, p=0.05). Support for compliance was more frequent in HIV-infected patients (23% vs. 7%, p=0.005). Conclusion. - The proportion of loss to follow-up was high. HIV infection was associated with a lower risk of loss to follow-up, likely to be due to more frequent support for compliance. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 30 条
[1]  
[Anonymous], [No title captured]
[2]  
[Anonymous], 2016, National Guidelines for Prevention and Management of HIV and STIs, Republic of Rwanda, Ministry of Health
[3]  
[Anonymous], [No title captured]
[4]  
[Anonymous], 2015, WHO GLOB TUB REP 201
[5]  
Antoine D., 2011, Bulletin Epidemiologique Hebdomadaire, P345
[6]   Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001 [J].
Antoine, Delphine ;
French, Clare E. ;
Jones, Jane ;
Watson, John M. .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2007, 61 (04) :302-307
[7]   Tuberculosis treatment adherence and fatality in Spain [J].
Cayla, Joan A. ;
Rodrigo, Teresa ;
Ruiz-Manzano, Juan ;
Caminero, Jose A. ;
Vidal, Rafael ;
Garcia, Jose M. ;
Blanquer, Rafael ;
Casals, Marti .
RESPIRATORY RESEARCH, 2009, 10
[8]   The impact of social conditions on patient adherence to pulmonary tuberculosis treatment [J].
Choi, H. ;
Chung, H. ;
Muntaner, C. ;
Lee, M. ;
Kim, Y. ;
Barry, C. E., III ;
Cho, S-N. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (07) :948-954
[9]   Risk factors for multidrug resistant tuberculosis in Europe: a systematic review [J].
Faustini, A ;
Hall, AJ ;
Perucci, CA .
THORAX, 2006, 61 (02) :158-163
[10]   Factors Associated with Tuberculosis Treatment Default in an Endemic Area of the Brazilian Amazon: A Case Control-Study [J].
Garrido, Marlucia da Silva ;
Penna, Maria Lucia ;
Perez-Porcuna, Tomas M. ;
de Souza, Alexandra Brito ;
Marreiro, Leni da Silva ;
Albuquerque, Bernardino Claudio ;
Martinez-Espinosa, Flor Ernestina ;
Buehrer-Sekula, Samira .
PLOS ONE, 2012, 7 (06)